Sarcoidosis News and Research

Latest Sarcoidosis News and Research

Immunologic diseases linked to poorer survival in PSC

Immunologic diseases linked to poorer survival in PSC

Fungal exposure in homes could increase risk of sarcoidosis

Fungal exposure in homes could increase risk of sarcoidosis

Researchers identify new genetic signature for sarcoidosis

Researchers identify new genetic signature for sarcoidosis

Sarcoidosis accounts for 25% of all deaths in African-American women

Sarcoidosis accounts for 25% of all deaths in African-American women

Various combinations of biomarkers are required to unequivocally diagnose specific disease

Various combinations of biomarkers are required to unequivocally diagnose specific disease

BU professor to study incidence of hypertension, diabetes and asthma in African American women

BU professor to study incidence of hypertension, diabetes and asthma in African American women

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Elevated rates of 'Sarcoid Like' Granulomatous Pulmonary Disease found in WTC responders

Elevated rates of 'Sarcoid Like' Granulomatous Pulmonary Disease found in WTC responders

Chest: January news briefs

Chest: January news briefs

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Twelve residents receive one-year fellowship grant to study medical dermatology

Twelve residents receive one-year fellowship grant to study medical dermatology

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments